Publication:
Lead inhibits paraoxonase 2 but not paraoxonase 1 activity in human hepatoma HepG2 cells

dc.contributor.authorSukketsiri W.
dc.contributor.authorPorntadavity S.
dc.contributor.authorPhivthong-Ngam L.
dc.contributor.authorLawanprasert S.
dc.date.accessioned2021-04-05T03:32:56Z
dc.date.available2021-04-05T03:32:56Z
dc.date.issued2013
dc.date.issuedBE2556
dc.description.abstractLead is an environmental toxicant of great concern for humans and animals. Lead-induced liver damage and malfunction are partly due to a disturbance of the cellular antioxidant balance. Paraoxonase 1 (PON1) and PON2 are highly expressed in the liver and have been proposed as antioxidative enzymes. In this study, the effects of lead on PON1 and PON2 activities were investigated in human hepatoma HepG2 cells by exposing the cells to various concentrations of lead acetate for 24, 48, or 72h. The results show that a significant increase in reactive oxygen species was observed even at the lowest concentration of lead treatment. However, only the highest concentration of lead significantly influenced cell viability. Lead had no influence on cell-associated PON1 activity, but it significantly decreased cytoplasmic PON2 activity in a concentration- and time-dependent manner. This reduction was rescued by the addition of calcium. A significant increase of PON2 transcript was observed by real-time polymerase chain reaction, while PON2 protein expression did not change in the western blot analysis. Taken together, these results indicate that lead reduces PON2, but not PON1, activity and that this reduction is reversed by calcium. Lead-induced oxidative stress and decreased PON2 activity lead to the upregulation of PON2 transcript. © 2012 John Wiley & Sons, Ltd.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of Applied Toxicology. Vol 33, No.7 (2013), p.631-637
dc.identifier.doi10.1002/jat.1789
dc.identifier.issn0260437X
dc.identifier.other2-s2.0-84878193221
dc.identifier.urihttps://hdl.handle.net/20.500.14740/6628
dc.rights.holderมหาวิทยาลัยศรีนครินทรวิโรฒ
dc.subject.otherAryldialkylphosphatase 1
dc.subject.otherAryldialkylphosphatase 2
dc.subject.otherCalcium
dc.subject.otherLead acetate
dc.subject.otherReactive oxygen metabolite
dc.subject.otherAdult
dc.subject.otherArticle
dc.subject.otherCancer cell culture
dc.subject.otherCell lysate
dc.subject.otherCell viability
dc.subject.otherConcentration response
dc.subject.otherControlled study
dc.subject.otherCytotoxicity
dc.subject.otherEnzyme activity
dc.subject.otherEnzyme inhibition
dc.subject.otherHepatoma cell
dc.subject.otherHuman
dc.subject.otherHuman cell
dc.subject.otherIn vitro study
dc.subject.otherLiver cell carcinoma
dc.subject.otherLiver toxicity
dc.subject.otherMolecular size
dc.subject.otherOxidative stress
dc.subject.otherPriority journal
dc.subject.otherProtein expression
dc.subject.otherReal time polymerase chain reaction
dc.subject.otherRNA extraction
dc.subject.otherSpectrophotometry
dc.subject.otherTreatment duration
dc.subject.otherUpregulation
dc.subject.otherWestern blotting
dc.subject.otherAryldialkylphosphatase
dc.subject.otherBlotting, Western
dc.subject.otherCalcium Chloride
dc.subject.otherCarcinoma, Hepatocellular
dc.subject.otherCell Line, Tumor
dc.subject.otherCell Survival
dc.subject.otherDrug-Induced Liver Injury
dc.subject.otherEnzyme Inhibitors
dc.subject.otherHumans
dc.subject.otherIndicators and Reagents
dc.subject.otherLiver Neoplasms
dc.subject.otherOrganometallic Compounds
dc.subject.otherReactive Oxygen Species
dc.subject.otherReal-Time Polymerase Chain Reaction
dc.subject.otherRNA
dc.subject.otherAnimalia
dc.titleLead inhibits paraoxonase 2 but not paraoxonase 1 activity in human hepatoma HepG2 cells
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84878193221&doi=10.1002%2fjat.1789&partnerID=40&md5=5ddadf00a425f7bb17c181c28b08d7db

Files